General

Woippy (France) – ABL Diagnostics (FR001400AHX6 – ABLD, the “Company”), a Euronext-listed company that develops molecular biology assays and software for microbiology laboratories is pleased to announce the expansion of its HIV genotyping menu of applications with the release of a new revolutionary assay, DeepChek® Assay HIV-1 Full PR/RT/INT Drug Resistance. The company keeps innovating

Woippy (France) – ABL Diagnostics (FR001400AHX6 – ABLD, the “Company”), a Euronext-listed company that develops molecular biology assays and software for microbiology laboratories is pleased to announce today the expansion of its network of exclusive distributors, able to offer the DeepChek® technology to laboratories willing to implement microbiology applications like HIV, SARS-CoV-2, Tuberculosis, Cytomegalovirus, Viral

DeepChek ® HCV / HBV / HDV Assays & Software Send Me More information

New kit Available !! Genotyping of the Full HIV-1 pol Gene with PR+RT+INT Regions in One Single PCR Reaction Send Me More information

ABL Diagnostics: A partner of choice for your scientific projects APHP (Assistance Publique Hôpitaux de Paris) // France Epidemiological and Molecular evolution of the HIV-1 CRF94: Birth of CRF 132  ♦♦♦ CHU Caen-Normandie // France Interest of HIV-1 Next-Generation Sequencing in a diagnosis laboratory in France ♦♦♦ CHU Amiens-Picardie // France Whole Genome Sequencing of

High-Resolution Bacterial identification through Whole 16s RNA Next Generation Sequencing

New Distribution Partnership with Biosistemi Grupa D.D.O. for 5 territories in the Balkans We are pleased to announce that we entered into a distribution agreement  of ABL’s Diagnostics line of products, including the DeepChek® Assays and software with Biosistemi Grupa d.o.o. for 5 territories:– Croatia– Montenegro– Kosovo– North Macedonia– Albania

Meet us at the 11th German-Austrian AIDS Congress (DÖAK 2023) Sehen wir uns beim #DÖAK? Vom 23. bis 25. März 2023 sind wir beim 11. Deutsch-Österreichischen AIDS-Kongress in Bonn! Besuchen Sie uns am Stand und freuen Sie sich auf drei Kongresstage mit einem umfangreichen Programm auf dem höchsten Stand der wissenschaftlichen Forschung.Unter dem Motto „HIV und

New Scientific Publication: From Capillary Electrophoresis to Deep Sequencing: An Improved HIV-1 Drug Resistance Assessment Solution Using In Vitro Diagnostic (IVD) Assays and Software We are pleased to share the release of our peer-reviewed article detailing the performances of the DeepChek® solution, reagents and software, which helps virologists and clinicians assessing HIV-1 Drug Resistance (HDR)